This article is a retraction of:
RETRACTED: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma
Frontiers Editorial Office*A Retraction of the Original Research Article
Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma
By Qu Y., Kang M., Cheng X., & Zhao J. (2020). Front. Oncol. 10:577280. doi: 10.3389/fonc.2020.577280
The Journal and Authors retract the 9 September 2020 article cited above for the following reasons provided by the Authors:
Following publication, concerns were raised regarding image manipulation. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Oncology and Chief Executive Editor. The authors agree to this retraction.
Citation: Frontiers Editorial Office (2021) Retraction: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma. Front. Oncol. 11:712966. doi: 10.3389/fonc.2021.712966
Received: 21 May 2021; Accepted: 21 May 2021;
Published: 10 June 2021.
Approved by:
Giuseppe Giaccone, Cornell University, United StatesCopyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org